HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · 在 SEC EDGAR 上查看 ↗
$420.53
价格 · 八月 19, 2026
截至...的财报数据 七月 28, 2026

关于 HCA Healthcare, Inc. Common Stock 公司概况(来自维基百科)

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

阅读更多

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

HCA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$420.53
市值
$94.45B
P/E (TTM)
14.8
每股收益 (TTM)
$28.33
营收 (TTM)
$75.60B
股息收益率
0.72%
ROE
-159.1%
负债/权益
-6.9
52周区间
$354 – $557

HCA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
EPS $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
自由现金流 $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
利润率 9.0%

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标
5年趋势
HCA
同行中位数
P/E (TTM)
5-point trend, +35.7%
14.8
20.3
P/S (TTM) (市销率 (TTM))
5-point trend, +3.8%
1.2
1.1
P/B (市净率)
5-point trend, +79.3%
-15.7
4.5
EV / EBITDA (企业价值 / EBITDA)
5-point trend, +5.5%
38.3
Price / FCF (股价/自由现金流)
5-point trend, -6.5%
12.3

盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
HCA
同行中位数
Net Profit Margin (净利润率)
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
HCA
同行中位数
Debt / Equity (负债/股东权益比率)
5-point trend, +81.4%
-6.9
Current Ratio (流动比率)
5-point trend, -31.7%
1.0
1.2
Quick Ratio (速动比率)
5-point trend, -26.9%
0.7

成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
HCA
同行中位数
Revenue YoY (营收同比增长)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (营收3年复合年增长率)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (营收5年复合年增长率)
5-point trend, +28.7%
8.0%
EPS YoY
5-point trend, +33.9%
28.8%
Net Income YoY (净利润同比增长)
5-point trend, -2.5%
17.8%

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
HCA
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, +33.9%
$28.33

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
HCA
同行中位数
Payout Ratio (派息率)
5-point trend, +11.6%
10.0%

股息 收益率、派息率、股息历史、5年CAGR

股息收益率
0.72%
派息率
10.0%
5年股息复合年增长率 (CAGR)
除息日金额
2026年6月16日$0.7800
2026年3月17日$0.7800
2025年12月15日$0.7200
2025年9月16日$0.7200
2025年6月16日$0.7200
2025年3月17日$0.7200
2024年12月13日$0.6600
2024年9月16日$0.6600
2024年6月14日$0.6600
2024年3月14日$0.6600
2023年12月13日$0.6000
2023年9月14日$0.6000
2023年6月15日$0.6000
2023年3月16日$0.6000
2022年12月13日$0.5600
2022年9月15日$0.5600
2022年6月15日$0.5600
2022年3月16日$0.5600
2021年12月13日$0.4800
2021年9月15日$0.4800

HCA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 30 位分析师
  • 强烈买入 6 20.0%
  • 买入 11 36.7%
  • 持有 12 40.0%
  • 卖出 1 3.3%
  • 强烈卖出 0 0.0%

12个月价格目标

21 位分析师 · 2026-08-17
中位数目标 $450.00 +7.0%
平均目标 $454.57 +8.1%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

平均惊喜
0.49%
期间 EPS Actual EPS 预期 惊喜
2026年6月30日 $7.62 $7.54 0.08%
2026年3月31日 $7.15 $7.21 -0.06%
2025年12月31日 $8.14 $7.53 0.61%
2025年9月30日 $6.96 $5.77 1.2%
2025年6月30日 $6.83 $6.31 0.52%
2025年3月31日 $6.45 $5.84 0.61%

同行比较(GICS 子行业) 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SNDA $612M -7.7 25.2% -18.6% -197.2%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 12
HCA 的年度损益表数据
指标 趋势 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
资产负债表 22
HCA 的年度资产负债表数据
指标 趋势 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
现金流 17
HCA 的年度现金流数据
指标 趋势 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
盈利能力 5
HCA 的年度盈利能力数据
指标 趋势 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
流动性与偿付能力 4
HCA 的年度流动性与偿付能力数据
指标 趋势 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
效率 2
HCA 的年度效率数据
指标 趋势 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
每股 6
HCA 的年度每股数据
指标 趋势 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
增长率 10
HCA 的年度增长率数据
指标 趋势 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
估值 (TTM) 17
HCA 的年度估值 (TTM)数据
指标 趋势 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $75.60B$70.60B$64.97B$60.23B$58.75B
净收入 $6.78B$5.76B$5.24B$5.64B$6.96B
稀释后每股收益 (EPS) $28.33$22.00$18.97$19.15$21.16
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
负债/股东权益比率 -6.9-17.2-22.3-13.8-37.1
流动比率 1.01.11.21.41.4
速动比率 0.70.80.91.01.0
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $7.69B$5.64B$4.69B$4.13B$5.38B

最新新闻 提及该公司的近期头条新闻

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存,并会跟随您浏览所有股票。

机构持有人 (13F) 1485 家申报者 · $39.4B 总计 · 截至 2026年6月30日

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
128 (-51 与上一季度对比) 174 (+70 与上一季度对比) 450 (-30 与上一季度对比) 555 (-4 与上一季度对比) +16.3M

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
VANGUARD GROUP INC $6118113464 13104814 15.53% 股份
VANGUARD CAPITAL MANAGEMENT LLC $3954150533 10141708 10.04% 股份
Sanders Capital, LLC $3442060818 8828287 8.74% 股份
STATE STREET CORP $2912102056 7469035 7.39% 股份
WELLINGTON MANAGEMENT GROUP LLP $1750298867 4489212 4.44% 股份
GEODE CAPITAL MANAGEMENT, LLC $1225259672 3159159 3.11% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $1057704509 2712828 2.68% 股份
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861456107 2209485 2.19% 股份
NORGES BANK $836457140 2145367 2.12% 股份
Capital World Investors $770864224 1977121 1.96% 股份
Capital International Investors $747403041 1916947 1.90% 股份
Crake Asset Management LLP $449072183 1151792 1.14% 股份
Metropolis Capital Ltd $430915307 910564 1.09% 股份
Darsana Capital Partners LP $428879000 1100000 1.09% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414533777 1063207 1.05% 股份
Life Cycle Investment Partners Ltd $355737196 912404 0.90% 股份
VANGUARD FIDUCIARY TRUST CO $339685814 871235 0.86% 股份
FMR LLC $325199295 834080 0.83% 股份
BARCLAYS PLC $299888573 769162 0.76% 股份
LYRICAL ASSET MANAGEMENT LP $255015742 654071 0.65% 股份
BlackRock, Inc. $240062291 615718 0.61% 股份
ROYAL LONDON ASSET MANAGEMENT LTD $235649908 604401 0.60% 股份
National Pension Service $230650346 591578 0.59% 股份
NORDEA INVESTMENT MANAGEMENT AB $230189125 594466 0.58% 股份
GOLDMAN SACHS GROUP INC $209775669 538038 0.53% 股份
Gobi Capital LLC $195742325 502045 0.50% 股份
Cryder Capital Partners LLP $194561738 499017 0.49% 股份
Swiss National Bank $172097446 441400 0.44% 股份
AustralianSuper Pty Ltd $159635782 409438 0.41% 股份
Consulta Ltd $155956000 400000 0.40% 股份
LEE DANNER & BASS INC $152150679 390240 0.39% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151472265 388500 0.38% 买入期权
Mitsubishi UFJ Asset Management Co., Ltd. $147943761 379450 0.38% 股份
DIMENSIONAL FUND ADVISORS LP $139697405 358300 0.35% 股份
Vanguard Global Advisers, LLC $136962509 351285 0.35% 股份
VIRGINIA RETIREMENT SYSTEMS ET Al $134838505 288820 0.34% 股份
ALLIANCEBERNSTEIN L.P. $134459788 284126 0.34% 股份
Sumitomo Mitsui Trust Group, Inc. $132794974 340596 0.34% 股份
TD Asset Management Inc $131847152 338165 0.33% 股份
Legal & General Group Plc $127805162 327798 0.32% 股份
California Public Employees Retirement System $124133958 318382 0.32% 股份
LAZARD ASSET MANAGEMENT LLC $120619879 309369 0.31% 股份
JANE STREET GROUP, LLC $119540274 306600 0.30% 买入期权
VANGUARD ASSET MANAGEMENT, Ltd $116069863 297699 0.29% 股份
CAPTRUST FINANCIAL ADVISORS $114741071 294291 0.29% 股份
ANTIPODES PARTNERS Ltd $113045096 289941 0.29% 股份
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109718328 231845 0.28% 股份
CITADEL ADVISORS LLC $105660190 271000 0.27% 买入期权
RHUMBLINE ADVISERS $97580413 250277 0.25% 股份
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97026076 248855 0.25% 股份
MACKENZIE FINANCIAL CORP $93597383 240061 0.24% 股份
BloombergSen Inc. $93160317 238940 0.24% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92247974 236600 0.23% 卖出期权
Brandywine Global Investment Management, LLC $89380814 191451 0.23% 股份
BANK OF AMERICA CORP /DE/ $89069981 228449 0.23% 股份
NEUBERGER BERMAN GROUP LLC $85926216 220386 0.22% 股份
MILFORD FUNDS LTD $82165029 210739 0.21% 股份
Bridgewater Associates, LP $79227208 203204 0.20% 股份
Prana Capital Management, LP $75552494 193779 0.19% 股份
DANSKE BANK A/S $73238497 187844 0.19% 股份
FRANKLIN RESOURCES INC $70965828 182015 0.18% 股份
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70445715 180681 0.18% 股份
Quantinno Capital Management LP $70407055 180581 0.18% 股份
ARGENT CAPITAL MANAGEMENT LLC $69149681 177357 0.18% 股份
Retirement Systems of Alabama $68081812 174618 0.17% 股份
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66167842 169709 0.17% 股份
BNP PARIBAS FINANCIAL MARKETS $64793090 166183 0.16% 股份
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64665206 165855 0.16% 股份
HSBC HOLDINGS PLC $64431534 165332 0.16% 股份
AVIVA PLC $64264789 164828 0.16% 股份
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64194533 135649 0.16% 股份
SEB Asset Management AB $63257255 162244 0.16% 股份
TODD ASSET MANAGEMENT LLC $62567208 160474 0.16% 股份
Swedbank AB $62528998 160376 0.16% 股份
W1M Investment Management Ltd $61247490 143647 0.16% 股份
HARRIS ASSOCIATES L P $60080879 154097 0.15% 股份
Ensign Peak Advisors, Inc $58372381 149715 0.15% 股份
NEW YORK STATE COMMON RETIREMENT FUND $57747778 148113 0.15% 股份
CITADEL ADVISORS LLC $57235852 146800 0.15% 卖出期权
Universal- Beteiligungs- und Servicegesellschaft mbH $57160993 146800 0.15% 股份
LOS ANGELES CAPITAL MANAGEMENT LLC $56512217 144944 0.14% 股份
Pictet Asset Management Holding SA $52147803 133739 0.13% 股份
VICTORY CAPITAL MANAGEMENT INC $50752761 130172 0.13% 股份
Pentwater Capital Management LP $50685700 130000 0.13% 股份
D. E. Shaw & Co., Inc. $50554307 129663 0.13% 股份
APG Asset Management N.V. $50368550 147699 0.13% 股份
AMF Tjanstepension AB $50355853 129154 0.13% 股份
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50349225 129137 0.13% 股份
EQUITABLE TRUST CO $49147974 126056 0.12% 股份
ENVESTNET ASSET MANAGEMENT INC $48919124 125469 0.12% 股份
CANADA PENSION PLAN INVESTMENT BOARD $48197812 123619 0.12% 股份
AMERICAN CENTURY COMPANIES INC $47460140 121727 0.12% 股份
OpenArc Corporate Advisory, LLC $47210610 121087 0.12% 股份
L1 Capital International Pty Ltd $46121648 118294 0.12% 股份
FIRST TRUST ADVISORS LP $44251579 113498 0.11% 股份
PFA Pension, Forsikringsaktieselskab $44046098 112971 0.11% 股份
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43830264 112417 0.11% 股份
EP Wealth Advisors, LLC $43287826 111026 0.11% 股份
WOLVERINE TRADING, LLC $42597104 101200 0.11% 买入期权
MERCER GLOBAL ADVISORS INC /ADV $42302070 108497 0.11% 股份

公司内部人士 91 位内幕人士 · 54 位高管 · 31 位董事

内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Samuel N Hazen CEO 2026年2月10日 F 64842 0 7 $-21483290
O'Boyle Michael P President & CEO - Parallon 2013年2月26日 A 21429 0 0 $0
Mike A Marks EVP and CFO 2026年5月7日 G 46576 0 0 $0
Bill B Rutherford CFO and EVP 2024年2月16日 F 22251 0 0 $0
Russell K Harms CFO - Central Group 2006年11月17日 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 2006年11月17日 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 2006年11月17日 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 2005年7月1日 F 13865 0 0 $0
Erol R Akdamar Group President 2024年11月12日 M 6843 0 0 $0
Timothy M Mcmanus Group President 2024年7月31日 M 27008 0 0 $0
Richard A Hammett Group President 2024年2月16日 F 17936 0 0 $0
Charles J Hall Group President 2022年11月11日 M 202443 0 0 $0
Bruce A Moore JR Group President - Service Line 2022年11月11日 S 30807 0 0 $0
Paul W Rutledge Group President 2012年12月31日 A 335657 0 0 $0
Beverly B Wallace President - Parallon 2011年11月2日 M 144714 0 0 $0
Charles Robert Evans President - Eastern Group 2006年7月26日 A 62173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 2005年10月27日 A 26154 0 0 $0
Greg Roth President-Ambulatory Surgery 2004年10月31日 D 9029 0 0 $0
Jay Grinney President-Eastern Group 2004年5月7日 D 24177 0 0 $0
Jon M Foster EVP and COO 2026年2月10日 F 23062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 2026年2月13日 M 8853 0 2 $-2747520
Jennifer Berres SVP & Chief Human Res. Officer 2026年2月11日 S 11993 0 2 $-4126932
Christopher F. Wyatt SVP & Controller 2026年2月11日 S 44379 0 1 $-2020000
Erica Rossitto SVP & Chief Nurse Executive 2026年2月10日 F 10407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 2026年2月10日 F 32080 0 1 $-747135
Sammie S Mosier SVP & Chief Nurse Executive 2025年2月13日 F 11113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 2024年11月14日 S 9454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 2024年11月12日 M 52702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 2024年8月5日 G 18526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 2024年7月29日 S 3510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 2024年7月25日 S 17755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 2024年5月9日 S 5185 0 0 $0
Chad J Wasserman SVP and CIO 2024年3月18日 M 1576 0 0 $0
Martin P. Paslick SVP and CIO 2023年4月12日 M 24643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 2021年11月9日 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 2021年5月5日 S 50062 0 0 $0
William J Morrow SVP - Finance and Treasurer 2021年2月18日 F 5578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 2021年2月18日 F 10122 0 0 $0
Victor L Campbell SVP-Government Affairs 2019年5月1日 A 194145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 2019年2月25日 M 84157 0 0 $0
Milton R Johnson Chairman 2019年2月25日 M 881823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 2018年2月25日 M 7003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 2018年2月25日 M 35546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 2018年2月25日 M 65199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 2017年5月23日 M 26378 0 0 $0
David Gwin Anderson SVP - Finance 2016年11月7日 M 110167 0 0 $0
Donald W Stinnett SVP & Controller 2016年2月25日 A 51965 0 0 $0
Noel B Williams SVP and CIO 2012年5月16日 M 299030 0 0 $0
Jack O Bovender JR Chairman 2009年10月6日 A 188340 0 0 $0
Carl V George SVP - Development 2009年2月27日 M 13092 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

激进投资者及 5%+ 股东 4 持仓

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 2026年2月10日 31.60% 初始申报 SEC
2006年11月22日 初始申报 SEC
Merrill Lynch Bank USA 2006年9月11日 初始申报 SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 2006年8月4日 初始申报 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF持仓 由 207 只交易所交易基金持有

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
IHF · iShares Trust 4.67% 141320 SH 2026年8月8日 每日
BUL · Pacer Funds Trust 3.91% 11437 NS 2026年4月30日 N-PORT
YALL · Tidal Trust I 3.61% 9261 NS 2026年5月31日 N-PORT
BWTG · ETF Opportunities Trust 3.02% 1646 NS 2026年5月31日 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2.32% 99335 SH 2026年8月8日 每日
ABIG · EA Series Trust 2.00% 2938 NS 2026年5月29日 N-PORT
FXH · First Trust Exchange-Traded Alpha... 1.99% 39985 NS 2026年4月30日 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1.67% 31685 SH 2026年8月8日 每日
COWZ · Pacer Funds Trust 1.64% 688264 NS 2026年4月30日 N-PORT
QQWZ · Pacer Funds Trust 1.64% 1762 NS 2026年4月30日 N-PORT
FEGE · RBB Fund Trust 1.46% 74706 NS 2026年5月31日 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1.39% 60385 SH 2026年8月8日 每日
RPG · Invesco Exchange-Traded Fund Trust 1.30% 63448 SH 2026年8月8日 每日
TMFE · RBB Fund, Inc. 1.29% 2892 NS 2026年5月31日 N-PORT
AMID · EA Series Trust 1.23% 3402 NS 2026年5月29日 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1.15% 7180 NS 2026年4月30日 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1.12% 6544 NS 2026年4月30日 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1.12% 73639 NS 2026年4月30日 N-PORT
SRHQ · Elevation Series Trust 1.10% 4883 NS 2026年4月30日 N-PORT
IYH · iShares Trust 0.99% 89420 SH 2026年8月8日 每日
NEAR · iShares U.S. ETF Trust 0.99% 48109000 SH 2026年8月8日 每日
CURE · Direxion Shares ETF Trust 0.98% 3122 NS 2026年4月30日 N-PORT
VHT · VANGUARD WORLD FUND 0.90% 470451 SH 2026年8月8日 每日
NFRA · FlexShares Trust 0.88% 62176 NS 2026年4月30日 N-PORT
REVS · Columbia ETF Trust I 0.87% 5693 NS 2026年4月30日 N-PORT
RXL · ProShares Trust 0.86% 1632 NS 2026年5月31日 N-PORT
DIVB · iShares Trust 0.85% 36806 SH 2026年8月8日 每日
BSCT · Invesco Exchange-Traded Self-Inde... 0.82% 24078000 2026年8月8日 每日
LSEQ · Harbor ETF Trust 0.81% 285 NS 2026年4月30日 N-PORT
IXJ · iShares Trust 0.80% 81465 SH 2026年8月8日 每日
BSCS · Invesco Exchange-Traded Self-Inde... 0.76% 26493000 2026年8月8日 每日
SPVM · Invesco Exchange-Traded Fund Trust 0.74% 2335 SH 2026年8月8日 每日
FTC · First Trust Exchange-Traded Alpha... 0.73% 21329 NS 2026年4月30日 N-PORT
RFFC · ALPS ETF Trust 0.68% 533 NS 2026年5月31日 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0.68% 2698 NS 2026年4月30日 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.67% 12075 SH 2026年8月8日 每日
VCEB · VANGUARD WORLD FUND 0.62% 8146000 PA 2026年8月8日 每日
FDMO · FIDELITY COVINGTON TRUST 0.61% 11771 NS 2026年4月30日 N-PORT
RECS · Columbia ETF Trust I 0.58% 72768 NS 2026年4月30日 N-PORT
AFLG · First Trust Exchange-Traded Fund ... 0.56% 9664 NS 2026年5月31日 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.55% 11876 SH 2026年8月8日 每日
VLLU · Harbor ETF Trust 0.54% 54 NS 2026年4月30日 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0.53% 7404 NS 2026年4月30日 N-PORT
WLDR · Two Roads Shared Trust 0.51% 844 NS 2026年4月30日 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0.50% 4620 NS 2026年5月31日 N-PORT
AKAF · ETF Series Solutions 0.50% 39 NS 2026年5月31日 N-PORT
BSCR · Invesco Exchange-Traded Self-Inde... 0.50% 22679000 2026年8月8日 每日
ROUS · Lattice Strategies Trust 0.47% 6388 NS 2026年4月30日 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0.46% 54218000 PA 2026年8月8日 每日
CGGR · Capital Group Growth ETF 0.45% 290273 NS 2026年5月31日 N-PORT